ASTRI New CEO Ir Dr Ted Suen on Board Next Month

ASTRI New CEO Ir Dr Ted Suen on Board Next Month

HONG KONG, June 16, 2025 /PRNewswire/ -- The Hong Kong Applied Science and Technology Research Institute (ASTRI) has announced the appointment of Ir Dr Ted Suen as its Chief Executive Officer (CEO), effective 2 July 2025, for a three-year term. Ir...

Nominations for Super Terminal Expo Awards 2025 Open from Now until September

Nominations for Super Terminal Expo Awards 2025 Open from Now until September

Recognising Innovation, Sustainability, and Excellence in Shaping Tomorrow's Transportation Hub HONG KONG, June 16, 2025 /PRNewswire/ -- Super Terminal Expo has announced the second edition of the Super Terminal Expo Awards 2025 – celebrating...

China Clean Expo 2026: Leveraging China's Booming Cleaning Market for Global Opportunities

China Clean Expo 2026: Leveraging China's Booming Cleaning Market for Global Opportunities

SHANGHAI, June 16, 2025 /PRNewswire/ -- The 27th China Clean Expo (CCE), organized by IM Sinoexpo and supported by ISSA – The Worldwide Cleaning Industry Association, the China Tourist Hotel Association, the China Commerce Association for General...

SDP Japan Raises $31 Million in Series D Round

SDP Japan Raises $31 Million in Series D Round

Pioneering the Future of Surgical Care in Response to Rising Demand TOKYO, June 16, 2025 /PRNewswire/ -- SDP Japan, Inc. (Shibuya-ku, Tokyo; CEO: Kazuhiko Nagayo), announced today that the Company has successfully raised approximately JPY 4.5...

Mastercard onboards customers up to four times faster with Cloud Edge

Mastercard onboards customers up to four times faster with Cloud Edge

Backed by leading cloud providers like AWS, Cloud Edge gives customers greater flexibility and choice SINGAPORE, June 16, 2025 /PRNewswire/ -- Mastercard today announced that Asia Pacific banks and fintechs can onboard to its network up to four...

ArkBio's New Drug Application for ADHD Therapeutic Azstarys Accepted and Granted Priority Review by China NMPA

ArkBio's New Drug Application for ADHD Therapeutic Azstarys Accepted and Granted Priority Review by China NMPA

SHANGHAI, June 16, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the National Medical Products Administration (NMPA) has officially accepted its New Drug Application (NDA) for Azstarys...

27th Shanghai International Film Festival Kicks Off with a Wave of Chinese Cinema

27th Shanghai International Film Festival Kicks Off with a Wave of Chinese Cinema

SHANGHAI, June 13, 2025 /PRNewswire/ -- The 27th Shanghai International Film Festival (SIFF) officially opened today, reaffirming its status as a premier platform for Chinese-language cinema. This year, 43 cinemas across Shanghai and 5 cinemas...

SABRE topline results: Cu-64 SAR-Bombesin is effective in detecting prostate cancer recurrence in patients with negative SOC imaging

SABRE topline results: Cu-64 SAR-Bombesin is effective in detecting prostate cancer recurrence in patients with negative SOC imaging

Highlights Topline data from Clarity's diagnostic Phase II trial, SABRE, showed that 64Cu-SAR-Bombesin was safe, well tolerated and effective at detecting prostate cancer in patients with biochemical recurrence (BCR) who are negative or equivocal on...

LANZAJET EXPANDS PARTNERSHIP WITH MICROSOFT TO STRENGTHEN THE COMPANY'S GLOBAL GROWTH

LANZAJET EXPANDS PARTNERSHIP WITH MICROSOFT TO STRENGTHEN THE COMPANY'S GLOBAL GROWTH

This agreement deepens multi-level collaboration with Microsoft across climate investment, renewable fuel offtake, and now digital infrastructure CHICAGO, June 12, 2025 /PRNewswire/ -- LanzaJet, Inc., a leading next-gen fuels technology company and...

Milvus 2.6: Built for Scale, Designed to Reduce Costs

Milvus 2.6: Built for Scale, Designed to Reduce Costs

REDWOOD SHORES, Calif., June 12, 2025 /PRNewswire/ -- Zilliz, the company behind the open-source vector database Milvus, today announced the release of Milvus 2.6, furthering the company's long-standing mission to democratize AI through accessible...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 115
  • menu
    menu